Hai Qian

Hai Qian

China Pharmaceutical University

H-index: 32

Asia-China

About Hai Qian

Hai Qian, With an exceptional h-index of 32 and a recent h-index of 23 (since 2020), a distinguished researcher at China Pharmaceutical University, specializes in the field of Medicinal Chemistry; Chemical Biology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Design, synthesis and bioactivity evaluation of novel fusion peptides and their CPT conjugates inducing effective anti-tumor responses on HER2 positive tumors

Novel CCR3-targeted cyclic peptides as potential therapeutic agents for age-related macular degeneration via inhibiting angiogenesis and reducing retinal photoreceptor damage

Discovery of novel HER2 targeting peptide-camptothecin conjugates with effective suppression for selective cancer treatment

AI-driven design of customized 3D-printed multi-layer capsules with controlled drug release profiles for personalized medicine

Novel dual-target FAAH and TRPV1 ligands as potential pharmacotherapeutics for pain management

Phenoxyacetic acid derivatives, preparation method thereof and use thereof as medicament

Exploration of Janus kinase (JAK) and histone deacetylase (HDAC) bispecific inhibitors based on the moiety of fedratinib for treatment of both hematologic malignancies and …

Novel dual-target μ‑opioid and TRPV1 ligands as potential pharmacotherapeutics for pain management

Hai Qian Information

University

Position

___

Citations(all)

3396

Citations(since 2020)

2151

Cited By

2112

hIndex(all)

32

hIndex(since 2020)

23

i10Index(all)

100

i10Index(since 2020)

72

Email

University Profile Page

China Pharmaceutical University

Google Scholar

View Google Scholar Profile

Hai Qian Skills & Research Interests

Medicinal Chemistry; Chemical Biology

Top articles of Hai Qian

Title

Journal

Author(s)

Publication Date

Design, synthesis and bioactivity evaluation of novel fusion peptides and their CPT conjugates inducing effective anti-tumor responses on HER2 positive tumors

Bioorganic & Medicinal Chemistry

Xiangyong Hao

Jiedan Deng

Honghua Zhang

Ziyi Liang

Fang Lei

...

2022/2/1

Novel CCR3-targeted cyclic peptides as potential therapeutic agents for age-related macular degeneration via inhibiting angiogenesis and reducing retinal photoreceptor damage

Bioorganic Chemistry

Yuanyuan Li

Xinjing Wu

Jiale Wan

Yonghui Guan

Chenghui Luo

...

2024/4/26

Discovery of novel HER2 targeting peptide-camptothecin conjugates with effective suppression for selective cancer treatment

Bioorganic Chemistry

Hanyu Wu

Yunxiao Liu

Jiaqi Zhou

Xiqi Meng

Hongyu Jiang

...

2024/4/15

AI-driven design of customized 3D-printed multi-layer capsules with controlled drug release profiles for personalized medicine

International Journal of Pharmaceutics

Jingzhi Hu

Jiale Wan

Junting Xi

Wei Shi

Hai Qian

2024/4/12

Novel dual-target FAAH and TRPV1 ligands as potential pharmacotherapeutics for pain management

European Journal of Medicinal Chemistry

Zhenrui Qiao

Shuyu Liu

Lei Jiang

Yunmeng Ma

Zhikang Zhang

...

2024/3/5

Phenoxyacetic acid derivatives, preparation method thereof and use thereof as medicament

2024/2/20

Exploration of Janus kinase (JAK) and histone deacetylase (HDAC) bispecific inhibitors based on the moiety of fedratinib for treatment of both hematologic malignancies and …

Journal of Medicinal Chemistry

Qianqian Qiu

Fanglian Chi

Daoguang Zhou

Zhancheng Xie

Yunxiao Liu

...

2023/4/14

Novel dual-target μ‑opioid and TRPV1 ligands as potential pharmacotherapeutics for pain management

Bioorganic Chemistry

Mengkang Gao

Yang Zhang

Bingxin Wang

Ning Guo

Lulian Shao

...

2023/2/1

Benzodiazepine compounds, and preparation method therefor and use thereof

2023/12/28

Advances in Tumor Antigen‐Based Anticancer Immunotherapy: Recent Progress, Prevailing Challenges, and Future Perspective

Wei Shi

Shuang Chen

Fanglian Chi

Qianqian Qiu

Yue Zhong

...

2023/2

An updated patent review of GPR40/FFAR1 modulators (2020–present)

Qiang Ren

Yiqing Fan

Lixin Yang

Mayu Shan

Wei Shi

...

2023/9/2

Research progress and challenges of TRPV1 channel modulators as a prospective therapy for diabetic neuropathic pain

Chunxia Liu

Ruoyang Miao

Faisal Raza

Hai Qian

Xin Tian

2023/1/5

Development of novel self‐assembled vaccines based on tumour‐specific antigenic peptide and TLR2 agonist for effective breast cancer immunotherapy via activating CD8+ T cells …

Immunology

Wei Shi

Zhenzhen Tong

Shuang Chen

Qianqian Qiu

Jiaqi Zhou

...

2023/8

Identification of highly efficacious PROTACs targeting BRD4 against acute myeloid leukemia: Design, synthesis, and biological evaluations

Chinese Chemical Letters

Aiping Chen

Yue Zhong

Yunxiao Liu

Zhancheng Xie

Hanyu Wu

...

2023/6/1

Effects of sleep apnea hypopnea syndromes on cardiovascular events: a systematic review and meta-analysis

Liang Xie

Penghao Zhen

Fuchao Yu

Xiaojin Yu

Hai Qian

...

2022/3/1

Structure-based discovery of receptor tyrosine kinase AXL degraders with excellent anti-tumor activity by selectively degrading AXL and inducing methuosis

European Journal of Medicinal Chemistry

Wei Shi

Ziying Feng

Fanglian Chi

Jiaqi Zhou

Qianqian Qiu

...

2022/4/15

Design, synthesis and biological evaluation of novel peptides with anti-cancer and drug resistance-reversing activities (vol 89, pg 540, 2015)

Future Journal of Pharmaceutical Sciences

Iten M Fawzy

Khairia M Youssef

Nasser SM Ismail

Joachim Gullbo

Khaled AM Abouzid

2015/6/1

Exploration of novel phthalazinone derivatives as potential efflux transporter inhibitors for reversing multidrug resistance and improving the oral absorption of paclitaxel

European Journal of Medicinal Chemistry

Wei Shi

Ping Zhang

Feng Zou

Jiaqi Zhou

Ziyu Yin

...

2022/4/5

Corrigendum to'Design, synthesis and biological evaluation of novel peptides with anti-cancer and drug resistance-reversing activities'[European Journal of Medicinal Chemistry …

Journal of Molecular Structure

Atamjit Singh

Kirandeep Kaur

Harneetpal Kaur

Pallvi Mohana

Saroj Arora

...

2023/10

Discovery of (S)–N-(3-isopropylphenyl)-2-(5-phenylthiazol-2-yl) pyrrolidine-1-carboxamide as potent and brain-penetrant TRPV1 antagonist

European Journal of Medicinal Chemistry

Yue Qiao

Yang Zhang

Zhenrui Qiao

Wenya He

Yingda Chen

...

2022/4/5

See List of Professors in Hai Qian University(China Pharmaceutical University)